David Siegel D, Oriol A, Rajnics P. et al. Updated results from ASPIRE and ENDEAVOR, randomised, open-label multicentre phase 3 studies of carfilzomib in patients with relapsed/refractory multiple myeloma (RRMM). EHA 2017, abstract P333.
15 jaar SWOG S0016: genezingskans met CHOP-regimes bij folliculair lymfoom
apr 2026 | Lymfoom, Radiotherapie